2016 annual financial data
Outlook Therapeutics 2016 Revenue growth
Direct answer
Revenue growth was -42.9%.
Operating income was -51,347,000 USD and net income was -53,302,000 USD.
Operating cash flow was Not available.
Get free Outlook Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,980,000 USD
- Operating income
- -51,347,000 USD
- Net income
- -53,302,000 USD
- Operating cash flow
- Not available